Here's Why You Should Buy Kronos Worldwide Stock Right Now

Kronos Worldwide's TiO2 sales volumes increased 10% year over year in the first half of 2026, while average selling prices rose 4% and management expects full-year net sales to exceed 2025. Second-quarter gross margin expanded to 18% from 13%, segment profit rose to $41.0 million from $10.9 million, and EBITDA increased to $52.9 million from $22.2 million. Operating cash flow improved to positive $2.0 million from an $81.7 million outflow, supported by restructuring savings, lower-cost inventory and inventory reduction to $498.3 million from $628.6 million at year-end 2025.

Analysis

KRO’s investment case is less about end-market growth than operating leverage to a normalized TiO2 cycle: incremental price realization and plant-utilization gains can expand EBITDA disproportionately because fixed-cost absorption remains the key swing factor. The more investable implication is that European trade barriers and logistics-driven import substitution may sustain regional pricing longer than the underlying 2-3% demand backdrop would imply. This favors European-exposed TiO2 capacity, but also raises the risk that KRO’s apparent share gains are temporary rather than evidence of a durable cost or product advantage.

The cash-flow inflection needs scrutiny. Working-capital release from inventory reduction can mask weak underlying conversion, so the next two quarters must demonstrate positive operating cash flow while receivables remain controlled and inventories do not rebuild. A reversal in Chinese export availability, easing freight costs, or a European coatings/construction slowdown would pressure both volumes and price realization; TiO2 producers historically move from tight pricing to oversupply quickly, making the equity highly sensitive to even modest utilization declines.

Consensus may underappreciate that KRO’s recovery is not necessarily unique. TROX is the cleaner liquid TiO2-cycle expression but carries greater balance-sheet and earnings volatility, while CC has less pure-play exposure but can monetize a broad chemical upcycle. KRO merits a tactical long only if quarterly margin improvement is accompanied by sustained cash conversion; otherwise, the prior share-price rerating has likely pulled forward a large portion of the restructuring benefit.

Key Decisions for Investors

• Initiate a small tactical long KRO over the next 1-3 months only on confirmation that third-quarter operating cash flow remains positive after working-capital movements; target a 15-20% upside from further EBITDA-estimate revisions, with a stop if gross margin falls below 16% or management retreats from full-year sales growth.
• Prefer a pair trade long KRO / short TROX for a 3-6 month horizon if European TiO2 pricing holds: KRO should retain the benefit of regional import displacement, while TROX has higher downside sensitivity to a global utilization setback. Exit if Chinese TiO2 export prices rise materially or TROX announces debt-reduction/cash-flow results that narrow its balance-sheet discount.
• Do not use IOSP, AVNT, or IPI as direct read-throughs; their earnings drivers are specialty chemicals, polymer compounding, and potash rather than TiO2. Treat their inclusion as promotional cross-selling rather than corroborating evidence for KRO.
• Set an alert for European coatings and construction indicators, Chinese TiO2 export pricing, and KRO inventory days over the next two earnings reports. Deterioration in any two of these signals would shift the stance from tactical long to no trade, as pricing-led margin gains would be unlikely to persist.